82 results
Page 3 of 5
6-K
EX-99.1
jc59wc9h335ko5u
6 Aug 19
Aurinia Pharmaceuticals Inc. 6-K
4:02pm
6-K
EX-99.2
akafyqp qv3
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
6-K
EX-99.1
h2uokjxuks r1ro
14 May 19
Current report (foreign)
4:04pm
6-K
EX-99.2
ggp446
14 May 19
Current report (foreign)
4:04pm
6-K
EX-99.1
gd0hwz1wqyhr
10 May 19
Aurinia Pharmaceuticals Inc. 6-K
7:00am
40-F
EX-99.1
04o2opt 37pg4e
19 Mar 19
Annual report (Canada)
4:16pm
40-F
bvzmmf6
19 Mar 19
Annual report (Canada)
4:16pm
40-F
EX-99.2
4ssp3j38brtl
19 Mar 19
Annual report (Canada)
4:16pm
40-F
EX-99.3
eriqyx43 pl
19 Mar 19
Annual report (Canada)
4:16pm
6-K
EX-99.1
o6mr3
22 Jan 19
Aurinia Pharmaceuticals Inc. 6-K
7:00am
6-K
EX-99.2
o9sfqenql5g7uqk3at22
30 Nov 18
Current report (foreign)
5:27pm
SUPPL
yu4lutja 79v2tsx3
30 Nov 18
Supplemental materials (foreign)
5:23pm
6-K
EX-99.1
5my5oxobl04
11 Jul 18
Aurinia Initiates Phase 2 Clinical Trial for Voclosporin Ophthalmic Solution for the Treatment of Dry Eye Syndrome
4:01pm
6-K/A
EX-99.3
yzj7fdrdyo72t
17 May 18
Current report (foreign) (amended)
12:00am
6-K
EX-99.1
c10t3scyt l7psu8q1c
20 Apr 17
Aurinia Pharmaceuticals Inc. 6-K
12:00am
6-K
EX-99.1
16o1 wwq1i
20 Apr 17
Aurinia Pharmaceuticals Inc. 6-K
12:00am
6-K
EX-99.1
4nfu6z9k743be
21 Nov 16
Aurinia Pharmaceuticals Inc. 6-K
12:00am
6-K
EX-99.1
ob8m9u 094
24 Oct 16
Aurinia Announces Acceptance of Late-Breaking Voclosporin Abstracts for Oral Presentation at Upcoming Medical Meetings
12:00am
6-K
EX-99.1
v3guk7qa7 uifvo1w
6 Oct 16
Aurinia Releases Open-Label AURION Data Demonstrating Increased Remission Rates over Time for Voclosporin in the Treatment of Lupus Nephritis
12:00am
F-10/A
autegccd06k16gr6w3j4
16 Oct 15
Registration of securities (Canada) (amended)
12:00am